These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 1370077

  • 1. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM, Grondin L, Carli M, Lima L, Reader TA.
    J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
    [Abstract] [Full Text] [Related]

  • 2. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM, Reader TA, Grondin L, Descarries L.
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [Abstract] [Full Text] [Related]

  • 3. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats.
    Datla KP, Curzon G.
    Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206
    [Abstract] [Full Text] [Related]

  • 4. Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.
    Molina-Holgado F, Molina-Holgado E, Leret ML, González MI, Reader TA.
    Neurochem Res; 1993 Nov; 18(11):1183-91. PubMed ID: 7504790
    [Abstract] [Full Text] [Related]

  • 5. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO, Bergström M, Eriksson K, Ross SB.
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [Abstract] [Full Text] [Related]

  • 6. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF, Arora RC, Schreiber MA, Meltzer HY.
    Biochem Pharmacol; 1991 Jan 01; 41(1):79-84. PubMed ID: 1702633
    [Abstract] [Full Text] [Related]

  • 7. Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei.
    Barden N, Daigle M, Picard V, Di Paolo T.
    J Neurochem; 1983 Sep 01; 41(3):834-40. PubMed ID: 6192216
    [Abstract] [Full Text] [Related]

  • 8. Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain.
    Berger UV, Grzanna R, Molliver ME.
    Exp Neurol; 1989 Feb 01; 103(2):111-5. PubMed ID: 2521470
    [Abstract] [Full Text] [Related]

  • 9. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G, Fernando JC, Marsden CA.
    Br J Pharmacol; 1978 Aug 01; 63(4):627-34. PubMed ID: 80243
    [Abstract] [Full Text] [Related]

  • 10. The effect of p-chloroamphetamine and p-chlorophenylalanine on the level of thyrotropin-releasing hormone and its receptors in some brain structures and lumbar spinal cord of the rat.
    Przegaliński E, Jaworska L, Gołembiowska K.
    Neuropeptides; 1992 Sep 01; 23(1):19-25. PubMed ID: 1383865
    [Abstract] [Full Text] [Related]

  • 11. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain.
    Zetterström TS, Pei Q, Madhav TR, Coppell AL, Lewis L, Grahame-Smith DG.
    Neuropharmacology; 1999 Jul 01; 38(7):1063-73. PubMed ID: 10428425
    [Abstract] [Full Text] [Related]

  • 12. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB, Kuyatt BL.
    Synapse; 1987 Jul 01; 1(5):488-96. PubMed ID: 2975068
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of idebenone (CV-2619) on metabolism of monoamines, especially serotonin, in the brain of normal rats and rats with cerebral ischemia.
    Narumi S, Nagai Y, Kakihana M, Yamazaki N, Nagaoka A, Nagawa Y.
    Jpn J Pharmacol; 1985 Mar 01; 37(3):235-44. PubMed ID: 2582171
    [Abstract] [Full Text] [Related]

  • 15. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.
    O'Connell MT, Portas CM, Sarna GS, Curzon G.
    Br J Pharmacol; 1991 Apr 01; 102(4):831-6. PubMed ID: 1713108
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic involvement in the cardiovascular stimulation by thyrotropin-releasing hormone (TRH) in anesthetized rats.
    Nurminen ML, Paakkari I, Seppälä T.
    Neurosci Lett; 1991 Jun 24; 127(2):147-9. PubMed ID: 1715540
    [Abstract] [Full Text] [Related]

  • 17. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product.
    Rattray M, Baldessari S, Gobbi M, Mennini T, Samanin R, Bendotti C.
    J Neurochem; 1996 Aug 24; 67(2):463-72. PubMed ID: 8764569
    [Abstract] [Full Text] [Related]

  • 18. Effect of p-chlorophenylalanine on cerebral serotonin binding, serotonin concentration and motor activity in the rat.
    Steigrad P, Tobler I, Waser PG, Borbély AA.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov 24; 305(2):143-8. PubMed ID: 153478
    [Abstract] [Full Text] [Related]

  • 19. Effects of idebenone on metabolism of monoamines and cyclic AMP formation in rats.
    Nagai Y, Narumi S, Kakihana M, Yamazaki N, Nagaoka A, Nagawa Y.
    Arch Gerontol Geriatr; 1989 May 24; 8(3):273-89. PubMed ID: 2475075
    [Abstract] [Full Text] [Related]

  • 20. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 24; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.